GSK’s Arexvy authorised by MHRA
10th July 2023 Uncategorised 0Therapy is the first respiratory syncytial virus vaccine specifically developed for older adults
More: GSK’s Arexvy authorised by MHRA
Source: News
Therapy is the first respiratory syncytial virus vaccine specifically developed for older adults
More: GSK’s Arexvy authorised by MHRA
Source: News
© 1994 - 2026 B.M. Pharmaceuticals